Press Releases 1999
Press Releases 1998

February 1999 Press Releases

THE FEMALE HEALTH COMPANY
FEMALE CONDOMS DISTRIBUTED TO HELP PROMOTE NATIONAL CONDOM WEEK

Chicago, February 9, 1999- In anticipation of Valentine's Day, The Female Health Company (OTCBB:  FCHO) has donated Female Condoms to colleges and universities across the country to help promote safer sex during National Condom Week. RealityÒ, The Female Condom, will be distributed at the following universities to help with the promotion of safer sex on campus:

University of Central Florida, Tulane University, University of Texas at Austin, Emory University, Louisiana State University, Michigan State University, University of Illinois at Chicago, Illinois State University, The George Washington University, Syracuse University, James Mason University, Mount Holyoke College, Eastern Illinois University, Cornell University, University of Oregon, Georgetown University, Georgia State University, Western Michigan University and many not-for profit agencies.

Female Condom samples have also been sent to area radio stations to be
distributed to their listeners. 

The Female Health Company has plans to continue its promotion of RealityÒ, to college students by participating in a number of promotions with a major male condom manufacturer for Spring Break 1999.

During National Condom Week, major drug chains such as American Drug (Osco/Sav-on), and Eckerd Drug will be promoting the RealityÒ, female condom Bonus Pak (containing 6 condoms for the price of 3) discounted $2.00 to $3.00 a box depending on the chain.  A total of 3,600 stores will participate.

The Female Health Company, based in Chicago, owns certain worldwide rights to The Female Condom including patents which have been issued in the United States, United Kingdom, Japan, France, Italy, Germany, Spain, The People's Republic of China, Canada, New Zealand, South Korea and Australia. The Female Condom is the only available product controlled by a woman that protects against sexually transmitted diseases including HIV/AIDS and unintended pregnancy.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: The statements in this release which are not historical fact are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of governmental regulations, both in the United States and abroad; the effects of competitive products and
pricing pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings. Actual events affecting the Company and the impact of such events on the Company's operations may vary from those currently anticipated.

 For more information about The Female Health Company toll-free via fax,

dial 1-800-PRO-INFO and enter company code "FHC."

Also, visit the Company’s web site, www.femalehealth.com.

Questions?  Comments?  E-mail us.